The effectiveness of transplant legislation, procedures and management: Cross-country evidence

dc.authorid BILGEL, FIRAT/0000-0002-2585-5975
dc.authorscopusid 36469673500
dc.contributor.author Bilgel, Firat
dc.date.accessioned 2024-05-25T11:24:36Z
dc.date.available 2024-05-25T11:24:36Z
dc.date.issued 2013
dc.department Okan University en_US
dc.department-temp Okan Univ, Dept Business Adm, TR-34959 Istanbul, Turkey en_US
dc.description BILGEL, FIRAT/0000-0002-2585-5975 en_US
dc.description.abstract This article investigates the impact of legal determinants of cadaveric and living donor organ transplantation rates using panel data on legislative, procedural and managerial aspects of organ transplantation and procurement, government health expenditures, enrollment rates, religious beliefs, legal systems and civil rights and liberties for 62 countries over a 2-year period. Under living donor organ transplantation, we found that guaranteeing traceability of organs by law or performing psychiatric evaluation to living donors has a sizeable, negative impact on living transplant rates once the remaining determinants of living transplantation have been controlled for. Under cadaveric transplantation, our findings do not suggest an unequivocal and positive association between presumed consent, donor registries and cadaveric transplant rates. However, legally requiring family consent or maintaining written procurement standards for deceased donors has a sizeable, negative impact on cadaveric transplant rates. The latter finding suggests that informing families rather than asking for consent may be an effective strategy to raise procurement rates while respecting patient autonomy. Finally, we confirm that predominantly non-Christian countries have significantly higher living but lower cadaveric transplant rates. (C) 2013 Elsevier Ireland Ltd. All rights reserved. en_US
dc.identifier.citationcount 6
dc.identifier.doi 10.1016/j.healthpol.2012.12.014
dc.identifier.endpage 242 en_US
dc.identifier.issn 0168-8510
dc.identifier.issue 2-3 en_US
dc.identifier.pmid 23347731
dc.identifier.scopus 2-s2.0-84876115416
dc.identifier.scopusquality Q1
dc.identifier.startpage 229 en_US
dc.identifier.uri https://doi.org/10.1016/j.healthpol.2012.12.014
dc.identifier.uri https://hdl.handle.net/20.500.14517/835
dc.identifier.volume 110 en_US
dc.identifier.wos WOS:000318332800015
dc.identifier.wosquality Q2
dc.language.iso en
dc.publisher Elsevier Ireland Ltd en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.scopus.citedbyCount 7
dc.subject Cadaveric transplantation en_US
dc.subject Living donor organ transplantation en_US
dc.subject Transplant legislation en_US
dc.subject Medical standards en_US
dc.subject Regression analysis en_US
dc.title The effectiveness of transplant legislation, procedures and management: Cross-country evidence en_US
dc.type Article en_US
dc.wos.citedbyCount 6

Files